Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Chemotherapy × irinotecan sucrosofate × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 32 Colorectal Neoplasms 15 Small Cell Lung Carcinoma 8 Neoplasms 8 Stomach Neoplasms 7 Biliary Tract Neoplasms 5 Neoplasm Metastasis 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Recurrence 3 Rectal Neoplasms 3 Osteosarcoma 3 Cholangiocarcinoma 3 Triple Negative Breast Neoplasms 2 Solid Tumor 2 Neuroblastoma 2 Nasopharyngeal Carcinoma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Wilms Tumor 1 Weight Loss 1 Somatostatinoma 1 Solid Tumor Cancer 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Refractory Solid Tumors 1

Interventions

irinotecan sucrosofate 1 Oxaliplatin 1 Neoadjuvant Therapy 1 Fluorouracil 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06172036 2023-12-15

CAPT-02

Zhejiang University

Phase 2 Not yet recruiting

Gastrointestinal

Neoadjuvant Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡